Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Jang, Gyu Beom ^a   Kim, Ji Young ^a   Cho, Sung Dae ^b   Park, Ki Soo ^c   Jung, Ji Youn ^d   Lee, Hwa Yong ^e   Hong, In Sun ^a   Nam, Jeong Seok ^a  

^a Gachon University   (South Korea)

^b Chonbuk National University   (South Korea)

^c Korea Health Industry Development Institute   (South Korea)

^d Kongju National University   (South Korea)

^e Jungwon University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FH535; FRZB PROTEIN; GLYCOPROTEIN; SULFONAMIDE;

ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; CANCER STEM CELL; DOSE RESPONSE; DRUG EFFECTS; FEMALE; METABOLISM; MOUSE; PATHOLOGY; SECONDARY; TREATMENT OUTCOME; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NEOPLASTIC STEM CELLS; SULFONAMIDES; TREATMENT OUTCOME; WNT SIGNALING PATHWAY;

EID: 84937880263     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12465     Document Type: Article

References (56)

1. Pang, R. et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 6, 603-15 (2010).
2. Hermann, P.C. et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313-23 (2007).
3. Mani, S.A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-15 (2008).
4. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J. , Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100, 3983-8 (2003).
5. Liu, H. et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Natl Acad Sci USA 107, 18115-20 (2010).
6. Eaves, C.J. , Humphries, R.K. Acute myeloid leukemia and the Wnt pathway. N Engl J Med 362, 2326-7 (2010).
7. Nusse, R. Wnt signaling and stem cell control. Cell Res 18, 523-7 (2008).
8. Reya, T. , Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843-50 (2005).
9. Monteiro, J. et al. Cancer stemness in Wnt-driven mammary tumorigenesis. Carcinogenesis 35, 2-13 (2014).
10. van Amerongen, R. , Nusse, R. Towards an integrated view of Wnt signaling in development. Development 136, 3205-14 (2009).
11. Pardal, R., Clarke, M.F. , Morrison, S.J. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3, 895-902 (2003).
12. Miyoshi, Y. et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1, 229-33 (1992).
13. Powell, S.M. et al. APC mutations occur early during colorectal tumorigenesis. Nature 359, 235-7 (1992).
14. van de Wetering, M. et al. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling. Cancer Res 61, 278-84 (2001).
15. Ugolini, F. et al. Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes. Oncogene 18, 1903-10 (1999).
16. Veeck, J. et al. Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene 25, 3479-88 (2006).
17. Klopocki, E. et al. Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. Int J Oncol 25, 641-9 (2004).
18. Chen, Y., Shi, H.Y., Stock, S.R., Stern, P.H. , Zhang, M. Regulation of breast cancer-induced bone lesions by beta-catenin protein signaling. J Biol Chem 286, 42575-84 (2011).
19. Dey, N. et al. Wnt signaling in triple negative breast cancer is associated with metastasis. BMC Cancer 13, 537 (2013).
20. Pacheco-Pinedo, E.C. et al. Wnt/beta-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium. J Clin Invest 121, 1935-45 (2011).
21. Yang, S., Zhang, J.J. , Huang, X.Y. Mouse models for tumor metastasis. Methods Mol Biol 928, 221-8 (2012).
22. Mao, J. et al. Roles of Wnt/beta-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment. Cell Death Dis 5, e1039 (2014).
23. MacDonald, B.T., Tamai, K. , He, X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17, 9-26 (2009).
24. Aslakson, C.J. , Miller, F.R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52, 1399-405 (1992).
25. Gan, X.Q. et al. Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction. J Cell Biol 180, 1087-100 (2008).
26. Charafe-Jauffret, E. et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 69, 1302-13 (2009).
27. Ricardo, S. et al. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J Clin Pathol 64, 937-46 (2011).
28. Grange, C., Lanzardo, S., Cavallo, F., Camussi, G. , Bussolati, B. Sca-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT transgenic mice. Neoplasia 10, 1433-43 (2008).
29. Singh, S.K. et al. Identification of human brain tumour initiating cells. Nature 432, 396-401 (2004).
30. Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-5 (2007).
31. Wellner, U. et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11, 1487-95 (2009).
32. Kim, R.J. et al. High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxiainducible factor-2alpha. Cancer Lett 333, 18-31 (2013).
33. Sheridan, C. et al. CD44+/CD24? breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 8, R59 (2006).
34. de Beca, F.F. et al. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types. J Clin Pathol 66, 187-91 (2013).
35. Shtutman, M. et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96, 5522-7 (1999).
36. Cai, C. , Zhu, X. The Wnt/beta-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer. Mol Med Rep 5, 1191-6 (2012).
37. Fukumoto, S. et al. Akt participation in the Wnt signaling pathway through Dishevelled. J Biol Chem 276, 17479-83 (2001).
38. Kaler, P., Godasi, B.N., Augenlicht, L. , Klampfer, L. The NF-kappaB/AKT-dependent Induction of Wnt Signaling in Colon Cancer Cells by Macrophages and IL-1beta. Cancer Microenviron 2, 69-80 (2009).
39. Yamaguchi, H. , Condeelis, J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 1773, 642-52 (2007).
40. Nobes, C.D., Hawkins, P., Stephens, L. , Hall, A. Activation of the small GTP-binding proteins rho and rac by growth factor receptors. J Cell Sci 108 (Pt 1) 225-33 (1995).
41. Lee, Y.T. Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol 23, 175-80 (1983).
42. Gangopadhyay, S., Nandy, A., Hor, P. , Mukhopadhyay, A. Breast cancer stem cells: a novel therapeutic target. Clin Breast Cancer 13, 7-15 (2013).
43. Hanahan, D. , Weinberg, R.A. Hallmarks of cancer: the next generation. Cell 144, 646-74 (2011).
44. Zardawi, S.J., O'Toole, S.A., Sutherland, R.L. , Musgrove, E.A. Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. Histol Histopathol 24, 385-98 (2009).
45. Lopez-Knowles, E. et al. Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients. Cancer Epidemiol Biomarkers Prev 19, 301-9 (2010).
46. Charafe-Jauffret, E. et al. ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program. Cancer Res 73, 7290-300 (2013).
47. Ginestier, C. et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555-67 (2007).
48. Cao, L. et al. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol 11, 71 (2011).
49. Grimshaw, M.J. et al. Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res 10, R52 (2008).
50. Pandit, T.S. et al. Lymphatic metastasis of breast cancer cells is associated with differential gene expression profiles that predict cancer stem cell-like properties and the ability to survive, establish and grow in a foreign environment. Int J Oncol 35, 297-308 (2009).
51. Fillmore, C.M. , Kuperwasser, C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10, R25 (2008).
52. Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537-49 (2003).
53. Minn, A.J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518-24 (2005).
54. Gupta, G.P. et al. ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci USA 104, 19506-11 (2007).
55. Nam, J.S. et al. Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res 68, 3915-23 (2008).
56. Nam, J.S. et al. Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells. Cancer Res 66, 7176-84 (2006).